Journal article
Constitutively active rhodopsin mutants causing night blindness are effectively phosphorylated by GRKs but differ in arrestin-1 binding
SA Vishnivetskiy, MK Ostermaier, A Singhal, V Panneels, KT Homan, A Glukhova, SG Sligar, JJG Tesmer, GFX Schertler, J Standfuss, VV Gurevich
Cellular Signalling | ELSEVIER SCIENCE INC | Published : 2013
Abstract
The effects of activating mutations associated with night blindness on the stoichiometry of rhodopsin interactions with G protein-coupled receptor kinase 1 (GRK1) and arrestin-1 have not been reported. Here we show that the monomeric form of WT rhodopsin and its constitutively active mutants M257Y, G90D, and T94I, reconstituted into HDL particles are effectively phosphorylated by GRK1, as well as two more ubiquitously expressed subtypes, GRK2 and GRK5. All versions of arrestin-1 tested (WT, pre-activated, and constitutively monomeric mutants) bind to monomeric rhodopsin and show the same selectivity for different functional forms of rhodopsin as in native disc membranes. Rhodopsin phosphoryl..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
The authors thank Dr. T. H. Bayburt for reconstituting native bovine rhodopsin into HDL particles. This study was supported in part by NIH grants EY011500, GM077561, GM081756 (V.V.G.), HL086865, HL071818, MH089378 (JJ.G.T.), GM033775 (S.G.S.), AHA grant N014938 (K.T.H.), Swiss National Science Foundation (S.N.S.F.) grant 31003A_132815 U.S. and G.FX.S.) and 31003A_141235 (J.S.).